<DOC>
	<DOCNO>NCT03070691</DOCNO>
	<brief_summary>This 22 week study ass efficacy , safety , tolerability LDE225 versus vehicle apply topically basal cell carcinoma ( BCC ) patient NBCCS . Patients treat multiple BCCs 12 week . Treatment success define complete clinical clearance complete histological clearance BCCs .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability Topically Applied LDE225 Cream ( Hedgehog Pathway Inhibitor ) Adult Patients With Nevoid Basal Cell Carcinoma Syndrome ( NBCCS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Basal Cell Nevus Syndrome</mesh_term>
	<criteria>1 . Adult great 18 year old , male female . 2 . Patient must able understand communicate investigator comply requirement study . 3 . Typical presentation NBCCS opinion investigator 4 . At least one major clinical criterion NBCCS . 5 . Multiple BCCs screening period 1 . Any concomitant dermatological disease could confound evaluation , base discretion investigator . 2 . Prior exposure LDE225 . 3 . Use systemic treatment BCC 4 week prior Baseline . 4 . Use topical treatment photodynamic therapy ( PDT ) 12 week prior Baseline . 5 . Use investigational drug Baseline , within 30 day 5 halflives prior Baseline , whichever longer . 6 . Clinically significant medical condition , per judgment investigator . 7 . History hypersensitivity ingredient study drug . 8 . Pregnant nursing ( lactate ) woman 9 . Women childbearing potential fertile male , UNLESS use two birth control methods Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Basal cell carcinoma</keyword>
	<keyword>Nevoid Basal Cell Carcinoma Syndrome</keyword>
	<keyword>NBCCS , Gorlin syndrome</keyword>
	<keyword>Gorlin-Goltz Syndrome</keyword>
	<keyword>Basal Cell Nevus Syndrome</keyword>
	<keyword>BCNS , Hedgehog pathway inhibitor</keyword>
	<keyword>topical</keyword>
	<keyword>Smoothened</keyword>
</DOC>